Plain-English translation of NCT06726642 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing whether a blood test that detects tiny pieces of cancer DNA can find cancer earlier in people who carry genetic mutations that increase their cancer risk. The researchers want to see if this blood test, when done regularly, can catch cancer at an earlier stage than standard screening methods—and whether doing so saves lives.
People with inherited cancer syndromes need frequent screening to catch cancer early, but current methods can miss cancers or detect them late. This study is testing whether a simple blood test could provide an easier, more frequent way to detect cancer earlier and improve outcomes for these high-risk families.
You likely qualify if…
You likely don't qualify if…
If you are randomly chosen for the treatment group, you will give blood samples every 4 months for 4 years—either at the study hospital or at a local lab, ideally when you're already having routine blood work done. Your blood samples will be tested for signs of cancer DNA, and you'll receive your results from the study team. If your test is positive, you'll be offered additional tests to confirm whether cancer is present. You'll also complete surveys and interviews about your experience with the blood test.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Canada